Neurotensin as an indicator for poor health outcomes in women

[News]

The satiety hormone neurotensin may provide a novel biomarker for assessing risk for diabetes, cardiovascular disease, and breast cancer among women, report researchers.

More... (http://www.news-medical.net/news/20121012/Neurotensin-as-an-indicator-for-poor-health-outcomes-in-women.aspx)